[시장보고서]동물용 정위 방사선 수술 시스템 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측

동물용 정위 방사선 수술 시스템 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Veterinary Stereotactic Radiosurgery System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F

상품코드 : 1714250

리서치사 : TechSci Research

발행일 : 2025년 04월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,497,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,940,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,550,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 동물용 정위 방사선 수술 시스템 시장은 2024년 34억 6,000만 달러로 평가되며, 2030년에는 62억 1,000만 달러로 성장할 것으로 예상되며, CAGR 10.22%를 반영할 것으로 예상됩니다.

이러한 성장의 원동력은 반려동물, 특히 개와 고양이의 암 유병률이 증가함에 따라 반려동물 보호자들이 첨단 비침습적 치료 솔루션을 찾게 된 데 따른 것입니다. 수의학 정위 방사선 수술(SRS)은 건강한 조직 손상을 최소화하면서 종양을 표적으로 하는 정확한 고선량 방사선 치료를 제공하며, SRS의 채택이 확대되는 배경에는 수의 종양학 옵션에 대한 인식이 높아지고, 동물의 특수한 요구에 맞는 장비에 대한 지속적인 기술 혁신이 있습니다. 혁신이 있습니다. 또한, 전 세계적으로 반려동물 사육이 증가하고 반려동물 건강관리 수준이 향상됨에 따라 고급 치료에 대한 접근성이 확대된 것도 시장 성장의 원동력이 되고 있습니다. 동물병원과 전문병원이 첨단 기술을 도입함에 따라 SRS 시스템에 대한 수요는 지속적으로 증가하고 있습니다. 또한, 수의 진단학 및 종양학의 발전으로 보다 정확하고 맞춤화된 치료가 가능해짐에 따라 선진국과 신흥 경제국 모두에서 이 시장 부문의 성장에 기여하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	34억 6,000만 달러
시장 규모 : 2030년	62억 1,000만 달러
CAGR : 2025-2030년	10.22%
급성장 부문	뇌종양
최대 시장	북미

시장 촉진요인

반려동물 양육 증가

주요 시장 과제

수의 종양 전문의 부족

주요 시장 동향

비침습적 치료에 대한 선호도 증가

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 제품별(감마 나이프, 선형 가속기, 양자선 방사선 치료(PBRT)/플래시 RT, 사이버 나이프)
- 용도별(뇌종양, 척수 종양, 기타 용도)
- 최종사용자별(동물 병원, 수의 전문 클리닉, 조사기관, 학술기관)
- 기업별(2024년)
- 지역별
시장 맵

제6장 북미의 동물용 정위 방사선 수술 시스템 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 멕시코
- 캐나다

제7장 유럽의 동물용 정위 방사선 수술 시스템 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 프랑스
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 동물용 정위 방사선 수술 시스템 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 한국
- 일본
- 호주

제9장 남미의 동물용 정위 방사선 수술 시스템 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 동물용 정위 방사선 수술 시스템 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제14장 경쟁 구도

Avante Health Solutions
Accuray Inc.
Elekta AB
Varian Medical Systems Inc.
PetCure Oncology
Xstrahl Inc.
CVS Group
Medtronic PLC
Nanovi AS
Merck & Co. Inc.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The Global Veterinary Stereotactic Radiosurgery System Market was valued at USD 3.46 billion in 2024 and is projected to grow to USD 6.21 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.22%. This growth is driven by the increasing prevalence of cancer among companion animals, especially dogs and cats, prompting pet owners to seek advanced and non-invasive treatment solutions. Veterinary stereotactic radiosurgery (SRS) offers precise, high-dose radiation therapy targeted at tumors while minimizing damage to healthy tissue. Its growing adoption is supported by rising awareness of veterinary oncology options, as well as continuous innovation in devices tailored for animal-specific needs. The market is further fueled by increasing global pet ownership and enhanced standards of pet healthcare, which have expanded access to sophisticated treatments. As veterinary clinics and specialty hospitals adopt more cutting-edge technologies, the demand for SRS systems continues to rise. Additionally, advancements in veterinary diagnostics and oncology are enabling more accurate, personalized care, contributing to the expansion of this market segment across both developed and emerging economies.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.46 Billion
Market Size 2030	USD 6.21 Billion
CAGR 2025-2030	10.22%
Fastest Growing Segment	Brain Tumours
Largest Market	North America

Key Market Drivers

Growing Pet Ownership

The expansion of global pet ownership is a pivotal factor in the growth of the Veterinary Stereotactic Radiosurgery System market. With more households adopting pets, there is a corresponding increase in demand for high-quality veterinary healthcare. Particularly in developed regions, pets are increasingly regarded as family members, prompting owners to pursue advanced treatments such as SRS. This trend is also extending to emerging markets where improved access to veterinary services is enabling broader adoption of cutting-edge solutions. As the pet population grows and owners become more informed about specialized care, the demand for precise, non-invasive cancer treatment options like SRS is expected to continue climbing.

Key Market Challenges

Limited Availability of Specialized Veterinary Oncologists

A significant challenge to the broader adoption of veterinary SRS systems is the shortage of trained veterinary oncologists capable of operating the complex equipment and designing effective treatment plans. The precision required for SRS treatment necessitates both technical and clinical expertise, which remains limited in many regions. Additionally, the cost and availability of training programs for veterinary professionals in oncology are insufficient to meet rising demand. These limitations, particularly in rural or underserved areas, hinder the deployment and effective utilization of SRS systems, slowing the market's overall penetration.

Key Market Trends

Increasing Preference for Non-Invasive Treatments

There is a marked shift toward non-invasive treatment methods in veterinary medicine, driven by heightened concern for animal welfare and the desire for improved recovery outcomes. Stereotactic radiosurgery offers an effective, pain-minimizing alternative to traditional surgery, particularly for treating brain and spinal tumors. With faster recovery times, reduced risk of complications, and minimal hospitalization, SRS is becoming increasingly preferred by pet owners and veterinarians alike. As non-invasive methods become more mainstream in both human and animal healthcare, the veterinary field is embracing technologies that enhance treatment precision and pet comfort.

Key Market Players

Avante Health Solutions
Accuray Inc.
Elekta AB
Varian Medical Systems Inc.
PetCure Oncology
Xstrahl Inc.
CVS Group
Medtronic PLC
Nanovi AS
Merck & Co. Inc.

Report Scope:

In this report, the Global Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Stereotactic Radiosurgery System Market, By Product:

Gamma Knife
LINAC
Proton Beam Radiation Therapy (PBRT)/ Flash-RT
CyberKnife

Veterinary Stereotactic Radiosurgery System Market, By Application:

Brain Tumours
Spinal Tumours
Other Applications

Veterinary Stereotactic Radiosurgery System Market, By End User:

Veterinary Hospitals
Veterinary Specialty Clinics
Research and Academic Institutions

Veterinary Stereotactic Radiosurgery System Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery System Market.

Available Customizations:

Global Veterinary Stereotactic Radiosurgery System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary Stereotactic Radiosurgery System Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
- 5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
- 5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
5.3. Market Map

6. North America Veterinary Stereotactic Radiosurgery System Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Veterinary Stereotactic Radiosurgery System Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End User
- 6.3.2. Mexico Veterinary Stereotactic Radiosurgery System Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End User
- 6.3.3. Canada Veterinary Stereotactic Radiosurgery System Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End User

7. Europe Veterinary Stereotactic Radiosurgery System Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Veterinary Stereotactic Radiosurgery System Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End User
- 7.3.2. Germany Veterinary Stereotactic Radiosurgery System Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Veterinary Stereotactic Radiosurgery System Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Veterinary Stereotactic Radiosurgery System Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Veterinary Stereotactic Radiosurgery System Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End User

8. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Veterinary Stereotactic Radiosurgery System Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End User
- 8.3.2. India Veterinary Stereotactic Radiosurgery System Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End User
- 8.3.3. South Korea Veterinary Stereotactic Radiosurgery System Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End User
- 8.3.4. Japan Veterinary Stereotactic Radiosurgery System Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Veterinary Stereotactic Radiosurgery System Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End User

9. South America Veterinary Stereotactic Radiosurgery System Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Veterinary Stereotactic Radiosurgery System Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Veterinary Stereotactic Radiosurgery System Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Veterinary Stereotactic Radiosurgery System Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End User

10. Middle East and Africa Veterinary Stereotactic Radiosurgery System Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Veterinary Stereotactic Radiosurgery System Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Veterinary Stereotactic Radiosurgery System Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Veterinary Stereotactic Radiosurgery System Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Avante Health Solutions
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Accuray Inc.
14.3. Elekta AB
14.4. Varian Medical Systems Inc.
14.5. PetCure Oncology
14.6. Xstrahl Inc.
14.7. CVS Group
14.8. Medtronic PLC
14.9. Nanovi AS
14.10. Merck & Co. Inc.